Figure 5
From: Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19
Dynamic trends in cytokine and chemokine levels during COVID-19 improvement. (A) Schematic diagram illustrating patients undergoing severe-to-mild transition in COVID-19. (B–I) Plasma levels of IL-2Rα, IL-5, IL-10, IP-10, HGF, SCGF-β, IL-16, and IL-18 in patients with mild, improved, and severe COVID-19. The p value was calculated using paired two-sided Student’s t tests. *P < 0.05, **P < 0.01.
